Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Gross Profit Over TimeStrong
Percentile Rank92
3Y CAGR+16.1%
Studio
Year-over-Year Change

Revenue minus cost of goods sold

3Y CAGR
+16.1%/yr
Annual compound
Percentile
P92
Near historical high
vs 3Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
TTM$99.56M-7.8%
2024$107.93M+34582.7%
2023$-313000.00-100.5%
2022$63.57M+124.3%
2021$-261.66M-7.0%
2020$-244.65M-
2019$0.00+100.0%
2018$-3.78M-295.5%
2017$-956000.00-149.6%
2016$-383000.00-